OESO-SEMPIRE 17th World Conference | Esophagus 2026 | Versailles | June 14-17, 2026

Session 33: Challenging cases in Oncology

Wednesday, June 17, 2:00 – 3:30 pm
Auditorium Condé

Chairs: Manfred Lutz – Christelle De la Fouchardière (France) – Dave Wang  

  1. HER2-Targeted Therapies:  new upcoming trials. – TBD
  2. Role of Immunotherapy for long-term survivorship. – Markus Moehler (Germany) 
  3. Claudin 18.2 Therapies for Gastroesophageal Cancer: full remission possible? – Jean-Philippe Metges (France)
  4. TNT a new option? – David Tougeron (France)
  5. CtDNA guidance? PLAGAST and more. – TBD
  6. Anti-EGFR + Immunotherapy for localized ESCC. – Baruch Brenner (Israel)
  7. Thinking out of the box with localized disease. – Ines Gockel (Switzerland)
  8. When de-escalation after first line? – Sara Lonardi (Italy)
  9. Liver limited disease: resect metastases like in colon cancer? – Beat Müller (Switzerland) 
  10. Surveillance after “cure”. – Alberto Puccini (Italy) 
  11. Lung metastases: important or not? – Anneli Elme